Important, Not Important

This week: ESG's crumblingCOVID on the rise, funding vanishesCalifornia's breadbasket at riskGene therapy pricingYour biometric data for sale, part 73Get more:Get more news, analysis, and Action Steps at newsletter.importantnotimportant.comGot feedback? Email us at questions@importantnotimportant.comFollow us on Twitter at @importantnotimpGet fun merch at importantnotimportant.com/storeTake a nap you deserve it